10:58 AM EDT, 03/19/2024 (MT Newswires) -- Cytek Biosciences ( CTKB ) said Tuesday it has appointed William McCombe as chief financial officer, effective immediately, and reaffirmed its full-year 2024 guidance.

McCombe succeeds Patrik Jeanmonod, who has served as the company's CFO since 2018. Jeanmonod has been appointed as head of corporate development analytics, the company said.

The company said it continues to expect 2024 revenue of $203 million to $213 million, and net income. Analysts surveyed by Capital IQ expect revenue of $207.9 million, and two analysts expect adjusted net income of $0.13 per share.

Price: 6.67, Change: -0.13, Percent Change: -1.91